12:00 AM
Aug 29, 2011
 |  BC Week In Review  |  Company News  |  Other News

Pfizer transplant, gastrointestinal news

Pfizer disclosed in an SEC filing that it voluntarily provided the U.S. Department of Justice and the SEC with information about potentially improper payments made by Pfizer and its Wyeth subsidiary in connection with certain sales activities outside the U.S. The DoJ is investigating Wyeth's promotional practices for gastroesophageal reflux disease (GERD) drug

Read the full 264 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >